Global Suvorexant Tablet Supply, Demand and Key Producers, 2026-2032
The global Suvorexant Tablet market size is expected to reach $ 270 million by 2032, rising at a market growth of -4.7% CAGR during the forecast period (2026-2032).
Suvorexant (brand name Belsomra) is a prescription medication used to treat insomnia, specifically helping adults fall asleep faster and stay asleep longer. It acts as a dual orexin receptor antagonist, blocking chemicals in the brain that promote wakefulness. It is taken orally, typically at a dose of 10-20 mg, 30 minutes before bed.
In 2025, the global production of Suvoresin tablets is 46.2 million tablets, with an average price of US$7.9 per tablet and an average gross profit margin of 81%.
Based on our research, the suvorexant market should be characterized as a highly focused single-molecule prescription drug market rather than a broad insomnia treatment segment. The appropriate scope is limited to finished oral tablets containing suvorexant and its associated supply chain, excluding other DORA drugs and traditional hypnotics. From a product perspective, suvorexant represents the first commercially successful dual orexin receptor antagonist, but its commercial performance remains heavily dependent on the BELSOMRA franchise rather than a multi-manufacturer expansion model.
From a supply structure standpoint, the finished dosage market remains highly concentrated, with Merck/MSD as the dominant player. Regional entities in Japan and Australia operate under the same corporate system, reinforcing the centralized nature of the finished drug segment. In contrast, the upstream API and intermediate supply chain is more diversified, with increasing participation from Chinese companies, particularly in custom synthesis, intermediate manufacturing, and potential generic pathways. This creates a dual-layer structure characterized by concentrated downstream commercialization and fragmented upstream supply.
From a demand perspective, suvorexant faces both structural support and competitive pressure. The DORA mechanism offers clinical advantages over traditional hypnotics, supporting its role in premium insomnia treatment. However, competing products such as lemborexant and daridorexant exert direct pressure on market share. As a result, while baseline demand is expected to remain stable, pricing dynamics and revenue growth are likely to weaken over time.
From a regulatory perspective, suvorexant operates under stricter frameworks compared to standard oral drugs, including controlled substance classification in the United States and additional prescription controls in other regions. These regulatory factors increase entry barriers for generics and suppliers, requiring not only chemical manufacturing capability but also compliance with regulatory, quality, and distribution requirements. Over time, the industry is expected to evolve from a single-originator model to a layered ecosystem involving originators, generic entrants, API suppliers, and specialized intermediate manufacturers.
This report studies the global Suvorexant Tablet production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Suvorexant Tablet and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Suvorexant Tablet that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Suvorexant Tablet total production and demand, 2021-2032, (K Tablets)
Global Suvorexant Tablet total production value, 2021-2032, (USD Million)
Global Suvorexant Tablet production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Tablets), (based on production site)
Global Suvorexant Tablet consumption by region & country, CAGR, 2021-2032 & (K Tablets)
U.S. VS China: Suvorexant Tablet domestic production, consumption, key domestic manufacturers and share
Global Suvorexant Tablet production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Tablets)
Global Suvorexant Tablet production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Tablets)
Global Suvorexant Tablet production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Tablets)
This report profiles key players in the global Suvorexant Tablet market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., MSD K.K., Merck Sharp & Dohme (Australia), Axplora Group, Zhejiang Huahai Pharmaceutical, Apino Pharma, Guangzhou Green Cross Pharmaceutical, Sandoo Pharmaceuticals and Chemicals, Nanjing Wedo Pharmatech, Unibest Industrial, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Suvorexant Tablet market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Tablets) and average price (US$/Tablet) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Suvorexant Tablet Market, By Region:
1. How big is the global Suvorexant Tablet market?
2. What is the demand of the global Suvorexant Tablet market?
3. What is the year over year growth of the global Suvorexant Tablet market?
4. What is the production and production value of the global Suvorexant Tablet market?
5. Who are the key producers in the global Suvorexant Tablet market?
6. What are the growth factors driving the market demand?
Suvorexant (brand name Belsomra) is a prescription medication used to treat insomnia, specifically helping adults fall asleep faster and stay asleep longer. It acts as a dual orexin receptor antagonist, blocking chemicals in the brain that promote wakefulness. It is taken orally, typically at a dose of 10-20 mg, 30 minutes before bed.
In 2025, the global production of Suvoresin tablets is 46.2 million tablets, with an average price of US$7.9 per tablet and an average gross profit margin of 81%.
Based on our research, the suvorexant market should be characterized as a highly focused single-molecule prescription drug market rather than a broad insomnia treatment segment. The appropriate scope is limited to finished oral tablets containing suvorexant and its associated supply chain, excluding other DORA drugs and traditional hypnotics. From a product perspective, suvorexant represents the first commercially successful dual orexin receptor antagonist, but its commercial performance remains heavily dependent on the BELSOMRA franchise rather than a multi-manufacturer expansion model.
From a supply structure standpoint, the finished dosage market remains highly concentrated, with Merck/MSD as the dominant player. Regional entities in Japan and Australia operate under the same corporate system, reinforcing the centralized nature of the finished drug segment. In contrast, the upstream API and intermediate supply chain is more diversified, with increasing participation from Chinese companies, particularly in custom synthesis, intermediate manufacturing, and potential generic pathways. This creates a dual-layer structure characterized by concentrated downstream commercialization and fragmented upstream supply.
From a demand perspective, suvorexant faces both structural support and competitive pressure. The DORA mechanism offers clinical advantages over traditional hypnotics, supporting its role in premium insomnia treatment. However, competing products such as lemborexant and daridorexant exert direct pressure on market share. As a result, while baseline demand is expected to remain stable, pricing dynamics and revenue growth are likely to weaken over time.
From a regulatory perspective, suvorexant operates under stricter frameworks compared to standard oral drugs, including controlled substance classification in the United States and additional prescription controls in other regions. These regulatory factors increase entry barriers for generics and suppliers, requiring not only chemical manufacturing capability but also compliance with regulatory, quality, and distribution requirements. Over time, the industry is expected to evolve from a single-originator model to a layered ecosystem involving originators, generic entrants, API suppliers, and specialized intermediate manufacturers.
This report studies the global Suvorexant Tablet production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Suvorexant Tablet and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Suvorexant Tablet that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Suvorexant Tablet total production and demand, 2021-2032, (K Tablets)
Global Suvorexant Tablet total production value, 2021-2032, (USD Million)
Global Suvorexant Tablet production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Tablets), (based on production site)
Global Suvorexant Tablet consumption by region & country, CAGR, 2021-2032 & (K Tablets)
U.S. VS China: Suvorexant Tablet domestic production, consumption, key domestic manufacturers and share
Global Suvorexant Tablet production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Tablets)
Global Suvorexant Tablet production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Tablets)
Global Suvorexant Tablet production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Tablets)
This report profiles key players in the global Suvorexant Tablet market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., MSD K.K., Merck Sharp & Dohme (Australia), Axplora Group, Zhejiang Huahai Pharmaceutical, Apino Pharma, Guangzhou Green Cross Pharmaceutical, Sandoo Pharmaceuticals and Chemicals, Nanjing Wedo Pharmatech, Unibest Industrial, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Suvorexant Tablet market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Tablets) and average price (US$/Tablet) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Suvorexant Tablet Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 5 mg Tablets
- 10 mg Tablets
- 15 mg Tablets
- 20 mg Tablets
- Other
- Approved Originator Product
- Approved Generic Product
- Generic Under Filing
- Sleep Onset Insomnia
- Sleep Maintenance Insomnia
- Mixed Insomnia
- Clinical Research
- Other
- Merck & Co.
- MSD K.K.
- Merck Sharp & Dohme (Australia)
- Axplora Group
- Zhejiang Huahai Pharmaceutical
- Apino Pharma
- Guangzhou Green Cross Pharmaceutical
- Sandoo Pharmaceuticals and Chemicals
- Nanjing Wedo Pharmatech
- Unibest Industrial
- Taizhou Sci-Healthoo Pharmaceutical Technology
- Shanghai Haoyuan Chemexpress
1. How big is the global Suvorexant Tablet market?
2. What is the demand of the global Suvorexant Tablet market?
3. What is the year over year growth of the global Suvorexant Tablet market?
4. What is the production and production value of the global Suvorexant Tablet market?
5. Who are the key producers in the global Suvorexant Tablet market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Suvorexant Tablet Introduction
1.2 World Suvorexant Tablet Supply & Forecast
1.2.1 World Suvorexant Tablet Production Value (2021 & 2025 & 2032)
1.2.2 World Suvorexant Tablet Production (2021-2032)
1.2.3 World Suvorexant Tablet Pricing Trends (2021-2032)
1.3 World Suvorexant Tablet Production by Region (Based on Production Site)
1.3.1 World Suvorexant Tablet Production Value by Region (2021-2032)
1.3.2 World Suvorexant Tablet Production by Region (2021-2032)
1.3.3 World Suvorexant Tablet Average Price by Region (2021-2032)
1.3.4 North America Suvorexant Tablet Production (2021-2032)
1.3.5 Europe Suvorexant Tablet Production (2021-2032)
1.3.6 China Suvorexant Tablet Production (2021-2032)
1.3.7 Japan Suvorexant Tablet Production (2021-2032)
1.3.8 India Suvorexant Tablet Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Suvorexant Tablet Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Suvorexant Tablet Major Market Trends
2 DEMAND SUMMARY
2.1 World Suvorexant Tablet Demand (2021-2032)
2.2 World Suvorexant Tablet Consumption by Region
2.2.1 World Suvorexant Tablet Consumption by Region (2021-2026)
2.2.2 World Suvorexant Tablet Consumption Forecast by Region (2027-2032)
2.3 United States Suvorexant Tablet Consumption (2021-2032)
2.4 China Suvorexant Tablet Consumption (2021-2032)
2.5 Europe Suvorexant Tablet Consumption (2021-2032)
2.6 Japan Suvorexant Tablet Consumption (2021-2032)
2.7 South Korea Suvorexant Tablet Consumption (2021-2032)
2.8 ASEAN Suvorexant Tablet Consumption (2021-2032)
2.9 India Suvorexant Tablet Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Suvorexant Tablet Production Value by Manufacturer (2021-2026)
3.2 World Suvorexant Tablet Production by Manufacturer (2021-2026)
3.3 World Suvorexant Tablet Average Price by Manufacturer (2021-2026)
3.4 Suvorexant Tablet Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Suvorexant Tablet Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Suvorexant Tablet in 2025
3.5.3 Global Concentration Ratios (CR8) for Suvorexant Tablet in 2025
3.6 Suvorexant Tablet Market: Overall Company Footprint Analysis
3.6.1 Suvorexant Tablet Market: Region Footprint
3.6.2 Suvorexant Tablet Market: Company Product Type Footprint
3.6.3 Suvorexant Tablet Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Suvorexant Tablet Production Value Comparison
4.1.1 United States VS China: Suvorexant Tablet Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Suvorexant Tablet Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Suvorexant Tablet Production Comparison
4.2.1 United States VS China: Suvorexant Tablet Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Suvorexant Tablet Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Suvorexant Tablet Consumption Comparison
4.3.1 United States VS China: Suvorexant Tablet Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Suvorexant Tablet Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Suvorexant Tablet Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Suvorexant Tablet Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Suvorexant Tablet Production Value (2021-2026)
4.4.3 United States Based Manufacturers Suvorexant Tablet Production (2021-2026)
4.5 China Based Suvorexant Tablet Manufacturers and Market Share
4.5.1 China Based Suvorexant Tablet Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Suvorexant Tablet Production Value (2021-2026)
4.5.3 China Based Manufacturers Suvorexant Tablet Production (2021-2026)
4.6 Rest of World Based Suvorexant Tablet Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Suvorexant Tablet Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Suvorexant Tablet Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Suvorexant Tablet Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Suvorexant Tablet Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 5 mg Tablets
5.2.2 10 mg Tablets
5.2.3 15 mg Tablets
5.2.4 20 mg Tablets
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Suvorexant Tablet Production by Type (2021-2032)
5.3.2 World Suvorexant Tablet Production Value by Type (2021-2032)
5.3.3 World Suvorexant Tablet Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY REGULATORY STATUS
6.1 World Suvorexant Tablet Market Size Overview by Regulatory Status: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Regulatory Status
6.2.1 Approved Originator Product
6.2.2 Approved Generic Product
6.2.3 Generic Under Filing
6.3 Market Segment by Regulatory Status
6.3.1 World Suvorexant Tablet Production by Regulatory Status (2021-2032)
6.3.2 World Suvorexant Tablet Production Value by Regulatory Status (2021-2032)
6.3.3 World Suvorexant Tablet Average Price by Regulatory Status (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Suvorexant Tablet Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Sleep Onset Insomnia
7.2.2 Sleep Maintenance Insomnia
7.2.3 Mixed Insomnia
7.2.4 Clinical Research
7.2.5 Other
7.3 Market Segment by Application
7.3.1 World Suvorexant Tablet Production by Application (2021-2032)
7.3.2 World Suvorexant Tablet Production Value by Application (2021-2032)
7.3.3 World Suvorexant Tablet Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Merck & Co.
8.1.1 Merck & Co. Details
8.1.2 Merck & Co. Major Business
8.1.3 Merck & Co. Suvorexant Tablet Product and Services
8.1.4 Merck & Co. Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Merck & Co. Recent Developments/Updates
8.1.6 Merck & Co. Competitive Strengths & Weaknesses
8.2 MSD K.K.
8.2.1 MSD K.K. Details
8.2.2 MSD K.K. Major Business
8.2.3 MSD K.K. Suvorexant Tablet Product and Services
8.2.4 MSD K.K. Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 MSD K.K. Recent Developments/Updates
8.2.6 MSD K.K. Competitive Strengths & Weaknesses
8.3 Merck Sharp & Dohme (Australia)
8.3.1 Merck Sharp & Dohme (Australia) Details
8.3.2 Merck Sharp & Dohme (Australia) Major Business
8.3.3 Merck Sharp & Dohme (Australia) Suvorexant Tablet Product and Services
8.3.4 Merck Sharp & Dohme (Australia) Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Merck Sharp & Dohme (Australia) Recent Developments/Updates
8.3.6 Merck Sharp & Dohme (Australia) Competitive Strengths & Weaknesses
8.4 Axplora Group
8.4.1 Axplora Group Details
8.4.2 Axplora Group Major Business
8.4.3 Axplora Group Suvorexant Tablet Product and Services
8.4.4 Axplora Group Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Axplora Group Recent Developments/Updates
8.4.6 Axplora Group Competitive Strengths & Weaknesses
8.5 Zhejiang Huahai Pharmaceutical
8.5.1 Zhejiang Huahai Pharmaceutical Details
8.5.2 Zhejiang Huahai Pharmaceutical Major Business
8.5.3 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Product and Services
8.5.4 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
8.5.6 Zhejiang Huahai Pharmaceutical Competitive Strengths & Weaknesses
8.6 Apino Pharma
8.6.1 Apino Pharma Details
8.6.2 Apino Pharma Major Business
8.6.3 Apino Pharma Suvorexant Tablet Product and Services
8.6.4 Apino Pharma Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Apino Pharma Recent Developments/Updates
8.6.6 Apino Pharma Competitive Strengths & Weaknesses
8.7 Guangzhou Green Cross Pharmaceutical
8.7.1 Guangzhou Green Cross Pharmaceutical Details
8.7.2 Guangzhou Green Cross Pharmaceutical Major Business
8.7.3 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Product and Services
8.7.4 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Guangzhou Green Cross Pharmaceutical Recent Developments/Updates
8.7.6 Guangzhou Green Cross Pharmaceutical Competitive Strengths & Weaknesses
8.8 Sandoo Pharmaceuticals and Chemicals
8.8.1 Sandoo Pharmaceuticals and Chemicals Details
8.8.2 Sandoo Pharmaceuticals and Chemicals Major Business
8.8.3 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Product and Services
8.8.4 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
8.8.6 Sandoo Pharmaceuticals and Chemicals Competitive Strengths & Weaknesses
8.9 Nanjing Wedo Pharmatech
8.9.1 Nanjing Wedo Pharmatech Details
8.9.2 Nanjing Wedo Pharmatech Major Business
8.9.3 Nanjing Wedo Pharmatech Suvorexant Tablet Product and Services
8.9.4 Nanjing Wedo Pharmatech Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Nanjing Wedo Pharmatech Recent Developments/Updates
8.9.6 Nanjing Wedo Pharmatech Competitive Strengths & Weaknesses
8.10 Unibest Industrial
8.10.1 Unibest Industrial Details
8.10.2 Unibest Industrial Major Business
8.10.3 Unibest Industrial Suvorexant Tablet Product and Services
8.10.4 Unibest Industrial Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Unibest Industrial Recent Developments/Updates
8.10.6 Unibest Industrial Competitive Strengths & Weaknesses
8.11 Taizhou Sci-Healthoo Pharmaceutical Technology
8.11.1 Taizhou Sci-Healthoo Pharmaceutical Technology Details
8.11.2 Taizhou Sci-Healthoo Pharmaceutical Technology Major Business
8.11.3 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Product and Services
8.11.4 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Taizhou Sci-Healthoo Pharmaceutical Technology Recent Developments/Updates
8.11.6 Taizhou Sci-Healthoo Pharmaceutical Technology Competitive Strengths & Weaknesses
8.12 Shanghai Haoyuan Chemexpress
8.12.1 Shanghai Haoyuan Chemexpress Details
8.12.2 Shanghai Haoyuan Chemexpress Major Business
8.12.3 Shanghai Haoyuan Chemexpress Suvorexant Tablet Product and Services
8.12.4 Shanghai Haoyuan Chemexpress Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Shanghai Haoyuan Chemexpress Recent Developments/Updates
8.12.6 Shanghai Haoyuan Chemexpress Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Suvorexant Tablet Industry Chain
9.2 Suvorexant Tablet Upstream Analysis
9.2.1 Suvorexant Tablet Core Raw Materials
9.2.2 Main Manufacturers of Suvorexant Tablet Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Suvorexant Tablet Production Mode
9.6 Suvorexant Tablet Procurement Model
9.7 Suvorexant Tablet Industry Sales Model and Sales Channels
9.7.1 Suvorexant Tablet Sales Model
9.7.2 Suvorexant Tablet Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Suvorexant Tablet Introduction
1.2 World Suvorexant Tablet Supply & Forecast
1.2.1 World Suvorexant Tablet Production Value (2021 & 2025 & 2032)
1.2.2 World Suvorexant Tablet Production (2021-2032)
1.2.3 World Suvorexant Tablet Pricing Trends (2021-2032)
1.3 World Suvorexant Tablet Production by Region (Based on Production Site)
1.3.1 World Suvorexant Tablet Production Value by Region (2021-2032)
1.3.2 World Suvorexant Tablet Production by Region (2021-2032)
1.3.3 World Suvorexant Tablet Average Price by Region (2021-2032)
1.3.4 North America Suvorexant Tablet Production (2021-2032)
1.3.5 Europe Suvorexant Tablet Production (2021-2032)
1.3.6 China Suvorexant Tablet Production (2021-2032)
1.3.7 Japan Suvorexant Tablet Production (2021-2032)
1.3.8 India Suvorexant Tablet Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Suvorexant Tablet Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Suvorexant Tablet Major Market Trends
2 DEMAND SUMMARY
2.1 World Suvorexant Tablet Demand (2021-2032)
2.2 World Suvorexant Tablet Consumption by Region
2.2.1 World Suvorexant Tablet Consumption by Region (2021-2026)
2.2.2 World Suvorexant Tablet Consumption Forecast by Region (2027-2032)
2.3 United States Suvorexant Tablet Consumption (2021-2032)
2.4 China Suvorexant Tablet Consumption (2021-2032)
2.5 Europe Suvorexant Tablet Consumption (2021-2032)
2.6 Japan Suvorexant Tablet Consumption (2021-2032)
2.7 South Korea Suvorexant Tablet Consumption (2021-2032)
2.8 ASEAN Suvorexant Tablet Consumption (2021-2032)
2.9 India Suvorexant Tablet Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Suvorexant Tablet Production Value by Manufacturer (2021-2026)
3.2 World Suvorexant Tablet Production by Manufacturer (2021-2026)
3.3 World Suvorexant Tablet Average Price by Manufacturer (2021-2026)
3.4 Suvorexant Tablet Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Suvorexant Tablet Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Suvorexant Tablet in 2025
3.5.3 Global Concentration Ratios (CR8) for Suvorexant Tablet in 2025
3.6 Suvorexant Tablet Market: Overall Company Footprint Analysis
3.6.1 Suvorexant Tablet Market: Region Footprint
3.6.2 Suvorexant Tablet Market: Company Product Type Footprint
3.6.3 Suvorexant Tablet Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Suvorexant Tablet Production Value Comparison
4.1.1 United States VS China: Suvorexant Tablet Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Suvorexant Tablet Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Suvorexant Tablet Production Comparison
4.2.1 United States VS China: Suvorexant Tablet Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Suvorexant Tablet Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Suvorexant Tablet Consumption Comparison
4.3.1 United States VS China: Suvorexant Tablet Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Suvorexant Tablet Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Suvorexant Tablet Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Suvorexant Tablet Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Suvorexant Tablet Production Value (2021-2026)
4.4.3 United States Based Manufacturers Suvorexant Tablet Production (2021-2026)
4.5 China Based Suvorexant Tablet Manufacturers and Market Share
4.5.1 China Based Suvorexant Tablet Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Suvorexant Tablet Production Value (2021-2026)
4.5.3 China Based Manufacturers Suvorexant Tablet Production (2021-2026)
4.6 Rest of World Based Suvorexant Tablet Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Suvorexant Tablet Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Suvorexant Tablet Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Suvorexant Tablet Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Suvorexant Tablet Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 5 mg Tablets
5.2.2 10 mg Tablets
5.2.3 15 mg Tablets
5.2.4 20 mg Tablets
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Suvorexant Tablet Production by Type (2021-2032)
5.3.2 World Suvorexant Tablet Production Value by Type (2021-2032)
5.3.3 World Suvorexant Tablet Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY REGULATORY STATUS
6.1 World Suvorexant Tablet Market Size Overview by Regulatory Status: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Regulatory Status
6.2.1 Approved Originator Product
6.2.2 Approved Generic Product
6.2.3 Generic Under Filing
6.3 Market Segment by Regulatory Status
6.3.1 World Suvorexant Tablet Production by Regulatory Status (2021-2032)
6.3.2 World Suvorexant Tablet Production Value by Regulatory Status (2021-2032)
6.3.3 World Suvorexant Tablet Average Price by Regulatory Status (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Suvorexant Tablet Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Sleep Onset Insomnia
7.2.2 Sleep Maintenance Insomnia
7.2.3 Mixed Insomnia
7.2.4 Clinical Research
7.2.5 Other
7.3 Market Segment by Application
7.3.1 World Suvorexant Tablet Production by Application (2021-2032)
7.3.2 World Suvorexant Tablet Production Value by Application (2021-2032)
7.3.3 World Suvorexant Tablet Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Merck & Co.
8.1.1 Merck & Co. Details
8.1.2 Merck & Co. Major Business
8.1.3 Merck & Co. Suvorexant Tablet Product and Services
8.1.4 Merck & Co. Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Merck & Co. Recent Developments/Updates
8.1.6 Merck & Co. Competitive Strengths & Weaknesses
8.2 MSD K.K.
8.2.1 MSD K.K. Details
8.2.2 MSD K.K. Major Business
8.2.3 MSD K.K. Suvorexant Tablet Product and Services
8.2.4 MSD K.K. Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 MSD K.K. Recent Developments/Updates
8.2.6 MSD K.K. Competitive Strengths & Weaknesses
8.3 Merck Sharp & Dohme (Australia)
8.3.1 Merck Sharp & Dohme (Australia) Details
8.3.2 Merck Sharp & Dohme (Australia) Major Business
8.3.3 Merck Sharp & Dohme (Australia) Suvorexant Tablet Product and Services
8.3.4 Merck Sharp & Dohme (Australia) Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Merck Sharp & Dohme (Australia) Recent Developments/Updates
8.3.6 Merck Sharp & Dohme (Australia) Competitive Strengths & Weaknesses
8.4 Axplora Group
8.4.1 Axplora Group Details
8.4.2 Axplora Group Major Business
8.4.3 Axplora Group Suvorexant Tablet Product and Services
8.4.4 Axplora Group Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Axplora Group Recent Developments/Updates
8.4.6 Axplora Group Competitive Strengths & Weaknesses
8.5 Zhejiang Huahai Pharmaceutical
8.5.1 Zhejiang Huahai Pharmaceutical Details
8.5.2 Zhejiang Huahai Pharmaceutical Major Business
8.5.3 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Product and Services
8.5.4 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
8.5.6 Zhejiang Huahai Pharmaceutical Competitive Strengths & Weaknesses
8.6 Apino Pharma
8.6.1 Apino Pharma Details
8.6.2 Apino Pharma Major Business
8.6.3 Apino Pharma Suvorexant Tablet Product and Services
8.6.4 Apino Pharma Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Apino Pharma Recent Developments/Updates
8.6.6 Apino Pharma Competitive Strengths & Weaknesses
8.7 Guangzhou Green Cross Pharmaceutical
8.7.1 Guangzhou Green Cross Pharmaceutical Details
8.7.2 Guangzhou Green Cross Pharmaceutical Major Business
8.7.3 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Product and Services
8.7.4 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Guangzhou Green Cross Pharmaceutical Recent Developments/Updates
8.7.6 Guangzhou Green Cross Pharmaceutical Competitive Strengths & Weaknesses
8.8 Sandoo Pharmaceuticals and Chemicals
8.8.1 Sandoo Pharmaceuticals and Chemicals Details
8.8.2 Sandoo Pharmaceuticals and Chemicals Major Business
8.8.3 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Product and Services
8.8.4 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
8.8.6 Sandoo Pharmaceuticals and Chemicals Competitive Strengths & Weaknesses
8.9 Nanjing Wedo Pharmatech
8.9.1 Nanjing Wedo Pharmatech Details
8.9.2 Nanjing Wedo Pharmatech Major Business
8.9.3 Nanjing Wedo Pharmatech Suvorexant Tablet Product and Services
8.9.4 Nanjing Wedo Pharmatech Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Nanjing Wedo Pharmatech Recent Developments/Updates
8.9.6 Nanjing Wedo Pharmatech Competitive Strengths & Weaknesses
8.10 Unibest Industrial
8.10.1 Unibest Industrial Details
8.10.2 Unibest Industrial Major Business
8.10.3 Unibest Industrial Suvorexant Tablet Product and Services
8.10.4 Unibest Industrial Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Unibest Industrial Recent Developments/Updates
8.10.6 Unibest Industrial Competitive Strengths & Weaknesses
8.11 Taizhou Sci-Healthoo Pharmaceutical Technology
8.11.1 Taizhou Sci-Healthoo Pharmaceutical Technology Details
8.11.2 Taizhou Sci-Healthoo Pharmaceutical Technology Major Business
8.11.3 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Product and Services
8.11.4 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Taizhou Sci-Healthoo Pharmaceutical Technology Recent Developments/Updates
8.11.6 Taizhou Sci-Healthoo Pharmaceutical Technology Competitive Strengths & Weaknesses
8.12 Shanghai Haoyuan Chemexpress
8.12.1 Shanghai Haoyuan Chemexpress Details
8.12.2 Shanghai Haoyuan Chemexpress Major Business
8.12.3 Shanghai Haoyuan Chemexpress Suvorexant Tablet Product and Services
8.12.4 Shanghai Haoyuan Chemexpress Suvorexant Tablet Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Shanghai Haoyuan Chemexpress Recent Developments/Updates
8.12.6 Shanghai Haoyuan Chemexpress Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Suvorexant Tablet Industry Chain
9.2 Suvorexant Tablet Upstream Analysis
9.2.1 Suvorexant Tablet Core Raw Materials
9.2.2 Main Manufacturers of Suvorexant Tablet Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Suvorexant Tablet Production Mode
9.6 Suvorexant Tablet Procurement Model
9.7 Suvorexant Tablet Industry Sales Model and Sales Channels
9.7.1 Suvorexant Tablet Sales Model
9.7.2 Suvorexant Tablet Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World SuvorexantTablet Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World SuvorexantTablet Production Value by Region (2021-2026) & (USD Million)
Table 3. World SuvorexantTablet Production Value by Region (2027-2032) & (USD Million)
Table 4. World SuvorexantTablet Production Value Market Share by Region (2021-2026)
Table 5. World SuvorexantTablet Production Value Market Share by Region (2027-2032)
Table 6. World SuvorexantTablet Production by Region (2021-2026) & (KTablets)
Table 7. World SuvorexantTablet Production by Region (2027-2032) & (KTablets)
Table 8. World SuvorexantTablet Production Market Share by Region (2021-2026)
Table 9. World SuvorexantTablet Production Market Share by Region (2027-2032)
Table 10. World SuvorexantTablet Average Price by Region (2021-2026) & (US$/Tablet)
Table 11. World SuvorexantTablet Average Price by Region (2027-2032) & (US$/Tablet)
Table 12. SuvorexantTablet Major Market Trends
Table 13. World SuvorexantTablet Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (KTablets)
Table 14. World SuvorexantTablet Consumption by Region (2021-2026) & (KTablets)
Table 15. World SuvorexantTablet Consumption Forecast by Region (2027-2032) & (KTablets)
Table 16. World SuvorexantTablet Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key SuvorexantTablet Producers in 2025
Table 18. World SuvorexantTablet Production by Manufacturer (2021-2026) & (KTablets)
Table 19. Production Market Share of Key SuvorexantTablet Producers in 2025
Table 20. World SuvorexantTablet Average Price by Manufacturer (2021-2026) & (US$/Tablet)
Table 21. Global SuvorexantTablet Company Evaluation Quadrant
Table 22. World SuvorexantTablet Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and SuvorexantTablet Production Site of Key Manufacturer
Table 24. SuvorexantTablet Market: Company Product Type Footprint
Table 25. SuvorexantTablet Market: Company Product Application Footprint
Table 26. SuvorexantTablet Competitive Factors
Table 27. SuvorexantTablet New Entrant and Capacity Expansion Plans
Table 28. SuvorexantTablet Mergers & Acquisitions Activity
Table 29. United States VS China SuvorexantTablet Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China SuvorexantTablet Production Comparison, (2021 & 2025 & 2032) & (KTablets)
Table 31. United States VS China SuvorexantTablet Consumption Comparison, (2021 & 2025 & 2032) & (KTablets)
Table 32. United States Based SuvorexantTablet Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers SuvorexantTablet Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers SuvorexantTablet Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers SuvorexantTablet Production (2021-2026) & (KTablets)
Table 36. United States Based Manufacturers SuvorexantTablet Production Market Share (2021-2026)
Table 37. China Based SuvorexantTablet Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers SuvorexantTablet Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers SuvorexantTablet Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers SuvorexantTablet Production, (2021-2026) & (KTablets)
Table 41. China Based Manufacturers SuvorexantTablet Production Market Share (2021-2026)
Table 42. Rest of World Based SuvorexantTablet Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers SuvorexantTablet Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers SuvorexantTablet Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers SuvorexantTablet Production, (2021-2026) & (KTablets)
Table 46. Rest of World Based Manufacturers SuvorexantTablet Production Market Share (2021-2026)
Table 47. World SuvorexantTablet Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World SuvorexantTablet Production by Type (2021-2026) & (KTablets)
Table 49. World SuvorexantTablet Production by Type (2027-2032) & (KTablets)
Table 50. World SuvorexantTablet Production Value by Type (2021-2026) & (USD Million)
Table 51. World SuvorexantTablet Production Value by Type (2027-2032) & (USD Million)
Table 52. World SuvorexantTablet Average Price by Type (2021-2026) & (US$/Tablet)
Table 53. World SuvorexantTablet Average Price by Type (2027-2032) & (US$/Tablet)
Table 54. World SuvorexantTablet Production Value by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Table 55. World SuvorexantTablet Production by Regulatory Status (2021-2026) & (KTablets)
Table 56. World SuvorexantTablet Production by Regulatory Status (2027-2032) & (KTablets)
Table 57. World SuvorexantTablet Production Value by Regulatory Status (2021-2026) & (USD Million)
Table 58. World SuvorexantTablet Production Value by Regulatory Status (2027-2032) & (USD Million)
Table 59. World SuvorexantTablet Average Price by Regulatory Status (2021-2026) & (US$/Tablet)
Table 60. World SuvorexantTablet Average Price by Regulatory Status (2027-2032) & (US$/Tablet)
Table 61. World SuvorexantTablet Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World SuvorexantTablet Production by Application (2021-2026) & (KTablets)
Table 63. World SuvorexantTablet Production by Application (2027-2032) & (KTablets)
Table 64. World SuvorexantTablet Production Value by Application (2021-2026) & (USD Million)
Table 65. World SuvorexantTablet Production Value by Application (2027-2032) & (USD Million)
Table 66. World SuvorexantTablet Average Price by Application (2021-2026) & (US$/Tablet)
Table 67. World SuvorexantTablet Average Price by Application (2027-2032) & (US$/Tablet)
Table 68. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 69. Merck & Co. Major Business
Table 70. Merck & Co. SuvorexantTablet Product and Services
Table 71. Merck & Co. SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Merck & Co. Recent Developments/Updates
Table 73. Merck & Co. Competitive Strengths & Weaknesses
Table 74. MSD K.K. Basic Information, Manufacturing Base and Competitors
Table 75. MSD K.K. Major Business
Table 76. MSD K.K. SuvorexantTablet Product and Services
Table 77. MSD K.K. SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. MSD K.K. Recent Developments/Updates
Table 79. MSD K.K. Competitive Strengths & Weaknesses
Table 80. Merck Sharp & Dohme (Australia) Basic Information, Manufacturing Base and Competitors
Table 81. Merck Sharp & Dohme (Australia) Major Business
Table 82. Merck Sharp & Dohme (Australia) SuvorexantTablet Product and Services
Table 83. Merck Sharp & Dohme (Australia) SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Merck Sharp & Dohme (Australia) Recent Developments/Updates
Table 85. Merck Sharp & Dohme (Australia) Competitive Strengths & Weaknesses
Table 86. Axplora Group Basic Information, Manufacturing Base and Competitors
Table 87. Axplora Group Major Business
Table 88. Axplora Group SuvorexantTablet Product and Services
Table 89. Axplora Group SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Axplora Group Recent Developments/Updates
Table 91. Axplora Group Competitive Strengths & Weaknesses
Table 92. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 93. Zhejiang Huahai Pharmaceutical Major Business
Table 94. Zhejiang Huahai Pharmaceutical SuvorexantTablet Product and Services
Table 95. Zhejiang Huahai Pharmaceutical SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 97. Zhejiang Huahai Pharmaceutical Competitive Strengths & Weaknesses
Table 98. Apino Pharma Basic Information, Manufacturing Base and Competitors
Table 99. Apino Pharma Major Business
Table 100. Apino Pharma SuvorexantTablet Product and Services
Table 101. Apino Pharma SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Apino Pharma Recent Developments/Updates
Table 103. Apino Pharma Competitive Strengths & Weaknesses
Table 104. Guangzhou Green Cross Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 105. Guangzhou Green Cross Pharmaceutical Major Business
Table 106. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Product and Services
Table 107. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Guangzhou Green Cross Pharmaceutical Recent Developments/Updates
Table 109. Guangzhou Green Cross Pharmaceutical Competitive Strengths & Weaknesses
Table 110. Sandoo Pharmaceuticals and Chemicals Basic Information, Manufacturing Base and Competitors
Table 111. Sandoo Pharmaceuticals and Chemicals Major Business
Table 112. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Product and Services
Table 113. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
Table 115. Sandoo Pharmaceuticals and Chemicals Competitive Strengths & Weaknesses
Table 116. Nanjing Wedo Pharmatech Basic Information, Manufacturing Base and Competitors
Table 117. Nanjing Wedo Pharmatech Major Business
Table 118. Nanjing Wedo Pharmatech SuvorexantTablet Product and Services
Table 119. Nanjing Wedo Pharmatech SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Nanjing Wedo Pharmatech Recent Developments/Updates
Table 121. Nanjing Wedo Pharmatech Competitive Strengths & Weaknesses
Table 122. Unibest Industrial Basic Information, Manufacturing Base and Competitors
Table 123. Unibest Industrial Major Business
Table 124. Unibest Industrial SuvorexantTablet Product and Services
Table 125. Unibest Industrial SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Unibest Industrial Recent Developments/Updates
Table 127. Unibest Industrial Competitive Strengths & Weaknesses
Table 128. Taizhou Sci-Healthoo Pharmaceutical Technology Basic Information, Manufacturing Base and Competitors
Table 129. Taizhou Sci-Healthoo Pharmaceutical Technology Major Business
Table 130. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Product and Services
Table 131. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Taizhou Sci-Healthoo Pharmaceutical Technology Recent Developments/Updates
Table 133. Taizhou Sci-Healthoo Pharmaceutical Technology Competitive Strengths & Weaknesses
Table 134. Shanghai Haoyuan Chemexpress Basic Information, Manufacturing Base and Competitors
Table 135. Shanghai Haoyuan Chemexpress Major Business
Table 136. Shanghai Haoyuan Chemexpress SuvorexantTablet Product and Services
Table 137. Shanghai Haoyuan Chemexpress SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Shanghai Haoyuan Chemexpress Recent Developments/Updates
Table 139. Shanghai Haoyuan Chemexpress Competitive Strengths & Weaknesses
Table 140. Global Key Players of SuvorexantTablet Upstream (Raw Materials)
Table 141. Global SuvorexantTablet Typical Customers
Table 142. SuvorexantTablet Typical Distributors
Table 1. World SuvorexantTablet Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World SuvorexantTablet Production Value by Region (2021-2026) & (USD Million)
Table 3. World SuvorexantTablet Production Value by Region (2027-2032) & (USD Million)
Table 4. World SuvorexantTablet Production Value Market Share by Region (2021-2026)
Table 5. World SuvorexantTablet Production Value Market Share by Region (2027-2032)
Table 6. World SuvorexantTablet Production by Region (2021-2026) & (KTablets)
Table 7. World SuvorexantTablet Production by Region (2027-2032) & (KTablets)
Table 8. World SuvorexantTablet Production Market Share by Region (2021-2026)
Table 9. World SuvorexantTablet Production Market Share by Region (2027-2032)
Table 10. World SuvorexantTablet Average Price by Region (2021-2026) & (US$/Tablet)
Table 11. World SuvorexantTablet Average Price by Region (2027-2032) & (US$/Tablet)
Table 12. SuvorexantTablet Major Market Trends
Table 13. World SuvorexantTablet Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (KTablets)
Table 14. World SuvorexantTablet Consumption by Region (2021-2026) & (KTablets)
Table 15. World SuvorexantTablet Consumption Forecast by Region (2027-2032) & (KTablets)
Table 16. World SuvorexantTablet Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key SuvorexantTablet Producers in 2025
Table 18. World SuvorexantTablet Production by Manufacturer (2021-2026) & (KTablets)
Table 19. Production Market Share of Key SuvorexantTablet Producers in 2025
Table 20. World SuvorexantTablet Average Price by Manufacturer (2021-2026) & (US$/Tablet)
Table 21. Global SuvorexantTablet Company Evaluation Quadrant
Table 22. World SuvorexantTablet Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and SuvorexantTablet Production Site of Key Manufacturer
Table 24. SuvorexantTablet Market: Company Product Type Footprint
Table 25. SuvorexantTablet Market: Company Product Application Footprint
Table 26. SuvorexantTablet Competitive Factors
Table 27. SuvorexantTablet New Entrant and Capacity Expansion Plans
Table 28. SuvorexantTablet Mergers & Acquisitions Activity
Table 29. United States VS China SuvorexantTablet Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China SuvorexantTablet Production Comparison, (2021 & 2025 & 2032) & (KTablets)
Table 31. United States VS China SuvorexantTablet Consumption Comparison, (2021 & 2025 & 2032) & (KTablets)
Table 32. United States Based SuvorexantTablet Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers SuvorexantTablet Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers SuvorexantTablet Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers SuvorexantTablet Production (2021-2026) & (KTablets)
Table 36. United States Based Manufacturers SuvorexantTablet Production Market Share (2021-2026)
Table 37. China Based SuvorexantTablet Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers SuvorexantTablet Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers SuvorexantTablet Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers SuvorexantTablet Production, (2021-2026) & (KTablets)
Table 41. China Based Manufacturers SuvorexantTablet Production Market Share (2021-2026)
Table 42. Rest of World Based SuvorexantTablet Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers SuvorexantTablet Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers SuvorexantTablet Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers SuvorexantTablet Production, (2021-2026) & (KTablets)
Table 46. Rest of World Based Manufacturers SuvorexantTablet Production Market Share (2021-2026)
Table 47. World SuvorexantTablet Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World SuvorexantTablet Production by Type (2021-2026) & (KTablets)
Table 49. World SuvorexantTablet Production by Type (2027-2032) & (KTablets)
Table 50. World SuvorexantTablet Production Value by Type (2021-2026) & (USD Million)
Table 51. World SuvorexantTablet Production Value by Type (2027-2032) & (USD Million)
Table 52. World SuvorexantTablet Average Price by Type (2021-2026) & (US$/Tablet)
Table 53. World SuvorexantTablet Average Price by Type (2027-2032) & (US$/Tablet)
Table 54. World SuvorexantTablet Production Value by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Table 55. World SuvorexantTablet Production by Regulatory Status (2021-2026) & (KTablets)
Table 56. World SuvorexantTablet Production by Regulatory Status (2027-2032) & (KTablets)
Table 57. World SuvorexantTablet Production Value by Regulatory Status (2021-2026) & (USD Million)
Table 58. World SuvorexantTablet Production Value by Regulatory Status (2027-2032) & (USD Million)
Table 59. World SuvorexantTablet Average Price by Regulatory Status (2021-2026) & (US$/Tablet)
Table 60. World SuvorexantTablet Average Price by Regulatory Status (2027-2032) & (US$/Tablet)
Table 61. World SuvorexantTablet Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World SuvorexantTablet Production by Application (2021-2026) & (KTablets)
Table 63. World SuvorexantTablet Production by Application (2027-2032) & (KTablets)
Table 64. World SuvorexantTablet Production Value by Application (2021-2026) & (USD Million)
Table 65. World SuvorexantTablet Production Value by Application (2027-2032) & (USD Million)
Table 66. World SuvorexantTablet Average Price by Application (2021-2026) & (US$/Tablet)
Table 67. World SuvorexantTablet Average Price by Application (2027-2032) & (US$/Tablet)
Table 68. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 69. Merck & Co. Major Business
Table 70. Merck & Co. SuvorexantTablet Product and Services
Table 71. Merck & Co. SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Merck & Co. Recent Developments/Updates
Table 73. Merck & Co. Competitive Strengths & Weaknesses
Table 74. MSD K.K. Basic Information, Manufacturing Base and Competitors
Table 75. MSD K.K. Major Business
Table 76. MSD K.K. SuvorexantTablet Product and Services
Table 77. MSD K.K. SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. MSD K.K. Recent Developments/Updates
Table 79. MSD K.K. Competitive Strengths & Weaknesses
Table 80. Merck Sharp & Dohme (Australia) Basic Information, Manufacturing Base and Competitors
Table 81. Merck Sharp & Dohme (Australia) Major Business
Table 82. Merck Sharp & Dohme (Australia) SuvorexantTablet Product and Services
Table 83. Merck Sharp & Dohme (Australia) SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Merck Sharp & Dohme (Australia) Recent Developments/Updates
Table 85. Merck Sharp & Dohme (Australia) Competitive Strengths & Weaknesses
Table 86. Axplora Group Basic Information, Manufacturing Base and Competitors
Table 87. Axplora Group Major Business
Table 88. Axplora Group SuvorexantTablet Product and Services
Table 89. Axplora Group SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Axplora Group Recent Developments/Updates
Table 91. Axplora Group Competitive Strengths & Weaknesses
Table 92. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 93. Zhejiang Huahai Pharmaceutical Major Business
Table 94. Zhejiang Huahai Pharmaceutical SuvorexantTablet Product and Services
Table 95. Zhejiang Huahai Pharmaceutical SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 97. Zhejiang Huahai Pharmaceutical Competitive Strengths & Weaknesses
Table 98. Apino Pharma Basic Information, Manufacturing Base and Competitors
Table 99. Apino Pharma Major Business
Table 100. Apino Pharma SuvorexantTablet Product and Services
Table 101. Apino Pharma SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Apino Pharma Recent Developments/Updates
Table 103. Apino Pharma Competitive Strengths & Weaknesses
Table 104. Guangzhou Green Cross Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 105. Guangzhou Green Cross Pharmaceutical Major Business
Table 106. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Product and Services
Table 107. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Guangzhou Green Cross Pharmaceutical Recent Developments/Updates
Table 109. Guangzhou Green Cross Pharmaceutical Competitive Strengths & Weaknesses
Table 110. Sandoo Pharmaceuticals and Chemicals Basic Information, Manufacturing Base and Competitors
Table 111. Sandoo Pharmaceuticals and Chemicals Major Business
Table 112. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Product and Services
Table 113. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
Table 115. Sandoo Pharmaceuticals and Chemicals Competitive Strengths & Weaknesses
Table 116. Nanjing Wedo Pharmatech Basic Information, Manufacturing Base and Competitors
Table 117. Nanjing Wedo Pharmatech Major Business
Table 118. Nanjing Wedo Pharmatech SuvorexantTablet Product and Services
Table 119. Nanjing Wedo Pharmatech SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Nanjing Wedo Pharmatech Recent Developments/Updates
Table 121. Nanjing Wedo Pharmatech Competitive Strengths & Weaknesses
Table 122. Unibest Industrial Basic Information, Manufacturing Base and Competitors
Table 123. Unibest Industrial Major Business
Table 124. Unibest Industrial SuvorexantTablet Product and Services
Table 125. Unibest Industrial SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Unibest Industrial Recent Developments/Updates
Table 127. Unibest Industrial Competitive Strengths & Weaknesses
Table 128. Taizhou Sci-Healthoo Pharmaceutical Technology Basic Information, Manufacturing Base and Competitors
Table 129. Taizhou Sci-Healthoo Pharmaceutical Technology Major Business
Table 130. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Product and Services
Table 131. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Taizhou Sci-Healthoo Pharmaceutical Technology Recent Developments/Updates
Table 133. Taizhou Sci-Healthoo Pharmaceutical Technology Competitive Strengths & Weaknesses
Table 134. Shanghai Haoyuan Chemexpress Basic Information, Manufacturing Base and Competitors
Table 135. Shanghai Haoyuan Chemexpress Major Business
Table 136. Shanghai Haoyuan Chemexpress SuvorexantTablet Product and Services
Table 137. Shanghai Haoyuan Chemexpress SuvorexantTablet Production (KTablets), Price (US$/Tablet), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Shanghai Haoyuan Chemexpress Recent Developments/Updates
Table 139. Shanghai Haoyuan Chemexpress Competitive Strengths & Weaknesses
Table 140. Global Key Players of SuvorexantTablet Upstream (Raw Materials)
Table 141. Global SuvorexantTablet Typical Customers
Table 142. SuvorexantTablet Typical Distributors
LIST OF FIGURES
Figure 1. SuvorexantTablet Picture
Figure 2. World SuvorexantTablet Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World SuvorexantTablet Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 5. World SuvorexantTablet Average Price (2021-2032) & (US$/Tablet)
Figure 6. World SuvorexantTablet Production Value Market Share by Region (2021-2032)
Figure 7. World SuvorexantTablet Production Market Share by Region (2021-2032)
Figure 8. North America SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 9. Europe SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 10. China SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 11. Japan SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 12. India SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 13. SuvorexantTablet Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 16. World SuvorexantTablet Consumption Market Share by Region (2021-2032)
Figure 17. United States SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 18. China SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 19. Europe SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 20. Japan SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 21. South Korea SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 22. ASEAN SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 23. India SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 24. Producer Shipments of SuvorexantTablet by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for SuvorexantTablet Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for SuvorexantTablet Markets in 2025
Figure 27. United States VS China: SuvorexantTablet Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: SuvorexantTablet Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: SuvorexantTablet Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers SuvorexantTablet Production Market Share 2025
Figure 31. China Based Manufacturers SuvorexantTablet Production Market Share 2025
Figure 32. Rest of World Based Manufacturers SuvorexantTablet Production Market Share 2025
Figure 33. World SuvorexantTablet Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World SuvorexantTablet Production Value Market Share by Type in 2025
Figure 35. 5 mgTablets
Figure 36. 10 mgTablets
Figure 37. 15 mgTablets
Figure 38. 20 mgTablets
Figure 39. Other
Figure 40. World SuvorexantTablet Production Market Share by Type (2021-2032)
Figure 41. World SuvorexantTablet Production Value Market Share by Type (2021-2032)
Figure 42. World SuvorexantTablet Average Price by Type (2021-2032) & (US$/Tablet)
Figure 43. World SuvorexantTablet Production Value by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Figure 44. World SuvorexantTablet Production Value Market Share by Regulatory Status in 2025
Figure 45. Approved Originator Product
Figure 46. Approved Generic Product
Figure 47. Generic Under Filing
Figure 48. World SuvorexantTablet Production Market Share by Regulatory Status (2021-2032)
Figure 49. World SuvorexantTablet Production Value Market Share by Regulatory Status (2021-2032)
Figure 50. World SuvorexantTablet Average Price by Regulatory Status (2021-2032) & (US$/Tablet)
Figure 51. World SuvorexantTablet Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World SuvorexantTablet Production Value Market Share by Application in 2025
Figure 53. Sleep Onset Insomnia
Figure 54. Sleep Maintenance Insomnia
Figure 55. Mixed Insomnia
Figure 56. Clinical Research
Figure 57. Other
Figure 58. World SuvorexantTablet Production Market Share by Application (2021-2032)
Figure 59. World SuvorexantTablet Production Value Market Share by Application (2021-2032)
Figure 60. World SuvorexantTablet Average Price by Application (2021-2032) & (US$/Tablet)
Figure 61. SuvorexantTablet Industry Chain
Figure 62. SuvorexantTablet Procurement Model
Figure 63. SuvorexantTablet Sales Model
Figure 64. SuvorexantTablet Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
Figure 1. SuvorexantTablet Picture
Figure 2. World SuvorexantTablet Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World SuvorexantTablet Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 5. World SuvorexantTablet Average Price (2021-2032) & (US$/Tablet)
Figure 6. World SuvorexantTablet Production Value Market Share by Region (2021-2032)
Figure 7. World SuvorexantTablet Production Market Share by Region (2021-2032)
Figure 8. North America SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 9. Europe SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 10. China SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 11. Japan SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 12. India SuvorexantTablet Production (2021-2032) & (KTablets)
Figure 13. SuvorexantTablet Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 16. World SuvorexantTablet Consumption Market Share by Region (2021-2032)
Figure 17. United States SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 18. China SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 19. Europe SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 20. Japan SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 21. South Korea SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 22. ASEAN SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 23. India SuvorexantTablet Consumption (2021-2032) & (KTablets)
Figure 24. Producer Shipments of SuvorexantTablet by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for SuvorexantTablet Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for SuvorexantTablet Markets in 2025
Figure 27. United States VS China: SuvorexantTablet Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: SuvorexantTablet Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: SuvorexantTablet Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers SuvorexantTablet Production Market Share 2025
Figure 31. China Based Manufacturers SuvorexantTablet Production Market Share 2025
Figure 32. Rest of World Based Manufacturers SuvorexantTablet Production Market Share 2025
Figure 33. World SuvorexantTablet Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World SuvorexantTablet Production Value Market Share by Type in 2025
Figure 35. 5 mgTablets
Figure 36. 10 mgTablets
Figure 37. 15 mgTablets
Figure 38. 20 mgTablets
Figure 39. Other
Figure 40. World SuvorexantTablet Production Market Share by Type (2021-2032)
Figure 41. World SuvorexantTablet Production Value Market Share by Type (2021-2032)
Figure 42. World SuvorexantTablet Average Price by Type (2021-2032) & (US$/Tablet)
Figure 43. World SuvorexantTablet Production Value by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Figure 44. World SuvorexantTablet Production Value Market Share by Regulatory Status in 2025
Figure 45. Approved Originator Product
Figure 46. Approved Generic Product
Figure 47. Generic Under Filing
Figure 48. World SuvorexantTablet Production Market Share by Regulatory Status (2021-2032)
Figure 49. World SuvorexantTablet Production Value Market Share by Regulatory Status (2021-2032)
Figure 50. World SuvorexantTablet Average Price by Regulatory Status (2021-2032) & (US$/Tablet)
Figure 51. World SuvorexantTablet Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World SuvorexantTablet Production Value Market Share by Application in 2025
Figure 53. Sleep Onset Insomnia
Figure 54. Sleep Maintenance Insomnia
Figure 55. Mixed Insomnia
Figure 56. Clinical Research
Figure 57. Other
Figure 58. World SuvorexantTablet Production Market Share by Application (2021-2032)
Figure 59. World SuvorexantTablet Production Value Market Share by Application (2021-2032)
Figure 60. World SuvorexantTablet Average Price by Application (2021-2032) & (US$/Tablet)
Figure 61. SuvorexantTablet Industry Chain
Figure 62. SuvorexantTablet Procurement Model
Figure 63. SuvorexantTablet Sales Model
Figure 64. SuvorexantTablet Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
